Eisai and Biogen Idec enter collaboration to develop and commercialize alzheimer’s disease treatments
5 March 2014 | By Biogen Idec
Agreement to enhance R&D capabilities and pipeline aimed at creating new therapies to suppress Alzheimer’s disease progression...